United States
Vernalis PLC Announces CTI Becomes Worldwide Licensee for Tosedostat
Vernalis plc today announces that CTI BioPharma Corp. (CTI), a US corporation publicly listed on NASDAQ, replaces the UK venture capital backed Chroma Therapeutics (Chroma) as worldwide licensee of tosedostat. CTI previously held rights to tosedostat in the Americas under a Licence Agreement with Chroma. Chroma no longer retains any ongoing rights or financial interest in tosedostat.
'Ouija' spells out win on U.S., Canada movie charts
"Ouija", a horror film inspired by the board said to contact the dead, haunted the top of movie charts in the United States and Canada, collecting $20 million in weekend ticket sales and knocking Brad Pitt's "Fury" out of first place.
Energy stocks attractive after steep sell-off: Barron's
A steep sell-off in energy company stocks in recent months due to falling oil prices may be overdone and there are some potential bargains to be had, Barron's financial newspaper said in its latest edition on Sunday.
Federal Reserve to take away the punch bowl
Unless it springs a major surprise, the U.S. Federal Reserve will call time this week on its program of government bond purchases, which at one point was pumping $85 billion a month into financial markets and the economy.




